(MedPage Today) — An adjuvant personalized DNA vaccine was safe and demonstrated promising efficacy among patients with MGMT-unmethylated glioblastoma in a phase I trial.
The vaccine caused no serious adverse events and extended overall survival…
Source link
Ad Banner
Show Comments (0)
Hide Comments (0)
Subscribe
Login
0 Comments
Oldest
